Vitiligo in patients with metastatic melanoma: a good prognostic sign - PubMed (original) (raw)
Vitiligo in patients with metastatic melanoma: a good prognostic sign
J J Nordlund et al. J Am Acad Dermatol. 1983 Nov.
Abstract
We have identified and studied twenty-seven patients with melanoma who also had vitiligo. Four patients had vitiligo before the diagnosis of melanoma, and twenty-three developed depigmentation after the diagnosis of malignancy. We also have reviewed published reports about twenty-four other patients with melanoma who developed vitiligo. The clinical course of the melanoma in the fifty-one patients was remarkably similar. Thirty-seven had a melanoma arising at a site which tends to carry a poor prognosis, for example, on the trunk, under the nail, or on the mucous membranes. Forty-nine patients had metastases in regional lymph nodes or at distal sites. Thirty-three patients survived 5 years, and twenty-five survived 10 years. These data suggest that the appearance of vitiligo in patients with metastatic melanoma portends a longer survival than expected. The patients with vitiligo are not necessarily cured and eventually may succumb to metastatic disease. We were unable to determine whether the vitiligo caused retardation of tumor growth or whether the melanoma caused vitiligo.
Similar articles
- Metastatic melanoma and vitiligo: a case report.
Buljan M, Situm M, Lugović L, Vucić M. Buljan M, et al. Acta Dermatovenerol Croat. 2006;14(2):100-3. Acta Dermatovenerol Croat. 2006. PMID: 16859616 - [Malignant melanoma, leukoderma and vitiligo].
Kraus L, Landthaler M. Kraus L, et al. Z Hautkr. 1980 Feb 15;55(4):218-31. Z Hautkr. 1980. PMID: 6996365 Review. German. - Complete regression of melanoma associated with vitiligo.
Piqué-Duran E, Palacios-Llopis S, Martínez-Martín M, Pérez-Cejudo JA. Piqué-Duran E, et al. Dermatol Online J. 2011 Jan 15;17(1):4. Dermatol Online J. 2011. PMID: 21272495 - Vitiligo associated with malignant melanoma and lupus erythematosus.
Gül U, Kiliç A, Tulunay O, Kaygusuz G. Gül U, et al. J Dermatol. 2007 Feb;34(2):142-5. doi: 10.1111/j.1346-8138.2006.00235.x. J Dermatol. 2007. PMID: 17239155 - Vitiligo and cutaneous melanoma. A case study.
Schallreuter KU, Levenig C, Berger J. Schallreuter KU, et al. Dermatologica. 1991;183(4):239-45. doi: 10.1159/000247693. Dermatologica. 1991. PMID: 1809584 Review.
Cited by
- Mendelian Randomization Analysis reveals Inverse Genetic Risks between Skin Cancers and Vitiligo.
Rashid S, Molotkov I, Klebanov N, Shaughnessy M, Daly MJ, Artomov M, Tsao H. Rashid S, et al. JID Innov. 2023 Jul 8;3(6):100217. doi: 10.1016/j.xjidi.2023.100217. eCollection 2023 Nov. JID Innov. 2023. PMID: 38034848 Free PMC article. - Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma.
Rosenberg MI, Greenstein E, Buchkovich M, Peres A, Santoni-Rugiu E, Yang L, Mikl M, Vaksman Z, Gibbs DL, Reshef D, Salovin A, Irwin MS, Naranjo A, Ulitsky I, de Alarcon PA, Matthay KK, Weigman V, Yaari G, Panzer JA, Friedman N, Maris JM. Rosenberg MI, et al. Cell Rep. 2023 Aug 29;42(8):112879. doi: 10.1016/j.celrep.2023.112879. Epub 2023 Aug 2. Cell Rep. 2023. PMID: 37537844 Free PMC article. - Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR.
Bayless NL, Bluestone JA, Bucktrout S, Butterfield LH, Jaffee EM, Koch CA, Roep BO, Sharpe AH, Murphy WJ, Villani AC, Walunas TL. Bayless NL, et al. J Immunother Cancer. 2021 Sep;9(9):e002627. doi: 10.1136/jitc-2021-002627. J Immunother Cancer. 2021. PMID: 34479924 Free PMC article. Review. - The Role of the NKG2D in Vitiligo.
Plaza-Rojas L, Guevara-Patiño JA. Plaza-Rojas L, et al. Front Immunol. 2021 Feb 26;12:624131. doi: 10.3389/fimmu.2021.624131. eCollection 2021. Front Immunol. 2021. PMID: 33717132 Free PMC article. Review. - Five-year survival with nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma.
Uhara H, Kiyohara Y, Uehara J, Fujisawa Y, Takenouchi T, Otsuka M, Uchi H, Fukushima S, Minami H, Hatsumichi M, Yamazaki N. Uhara H, et al. J Dermatol. 2021 May;48(5):592-599. doi: 10.1111/1346-8138.15804. Epub 2021 Mar 14. J Dermatol. 2021. PMID: 33715172 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical